<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Blog - The Capture</title>
    <link>https://thepharmaforce.com/blog/the-capture</link>
    <description>340B compliance, contract pharmacy strategy, and program intelligence delivered straight to your inbox. Subscribe to The Refill, PharmaForce's blog for covered entity leaders.</description>
    <language>en-us</language>
    <pubDate>Mon, 06 Apr 2026 14:30:44 GMT</pubDate>
    <dc:date>2026-04-06T14:30:44Z</dc:date>
    <dc:language>en-us</dc:language>
    <item>
      <title>AI in 340B: Managing Today's Complexity with 2019 Effort</title>
      <link>https://thepharmaforce.com/blog/the-capture/ai-in-340b-managing-todays-complexity-with-2019-effort</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://thepharmaforce.com/blog/the-capture/ai-in-340b-managing-todays-complexity-with-2019-effort" title="" class="hs-featured-image-link"&gt; &lt;img src="https://thepharmaforce.com/hubfs/tablet%202.png" alt="AI in 340B: Managing Today's Complexity with 2019 Effort" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;At the 340B Winter Conference 2026, PharmaForce Chief Product Officer Anthony Velasquez took the stage to talk about something every 340B program manager knows but rarely gets to say out loud: the job has gotten exponentially harder, and the tools haven't kept up.&lt;/p&gt; 
&lt;p&gt;He opened with a story. Years ago, managing a 340B program with three EMRs, three TPAs, and a psych clinic still on paper charts, he fell asleep at his desk doing audits — two months behind and dreading every second of it. If you've managed a 340B program, that probably sounds familiar.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://thepharmaforce.com/blog/the-capture/ai-in-340b-managing-todays-complexity-with-2019-effort" title="" class="hs-featured-image-link"&gt; &lt;img src="https://thepharmaforce.com/hubfs/tablet%202.png" alt="AI in 340B: Managing Today's Complexity with 2019 Effort" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;At the 340B Winter Conference 2026, PharmaForce Chief Product Officer Anthony Velasquez took the stage to talk about something every 340B program manager knows but rarely gets to say out loud: the job has gotten exponentially harder, and the tools haven't kept up.&lt;/p&gt; 
&lt;p&gt;He opened with a story. Years ago, managing a 340B program with three EMRs, three TPAs, and a psych clinic still on paper charts, he fell asleep at his desk doing audits — two months behind and dreading every second of it. If you've managed a 340B program, that probably sounds familiar.&lt;/p&gt;  
&lt;img src="https://track.hubspot.com/__ptq.gif?a=46431067&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fthepharmaforce.com%2Fblog%2Fthe-capture%2Fai-in-340b-managing-todays-complexity-with-2019-effort&amp;amp;bu=https%253A%252F%252Fthepharmaforce.com%252Fblog%252Fthe-capture&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>AI</category>
      <pubDate>Fri, 27 Mar 2026 20:39:49 GMT</pubDate>
      <author>marketing@thepharmaforce.com (PharmaForce)</author>
      <guid>https://thepharmaforce.com/blog/the-capture/ai-in-340b-managing-todays-complexity-with-2019-effort</guid>
      <dc:date>2026-03-27T20:39:49Z</dc:date>
    </item>
    <item>
      <title>The 340B Rebate Model: What Just Happened and What Comes Next</title>
      <link>https://thepharmaforce.com/blog/the-capture/the-340b-rebate-model-what-just-happened-and-what-comes-next</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://thepharmaforce.com/blog/the-capture/the-340b-rebate-model-what-just-happened-and-what-comes-next" title="" class="hs-featured-image-link"&gt; &lt;img src="https://thepharmaforce.com/hubfs/Capital%20Hill%20-%20The%20Capture.jpg" alt="The 340B Rebate Model: What Just Happened and What Comes Next" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;div style="color: #1a1a1a;"&gt; 
 &lt;h2 style="background-color: white; color: #5a5a6e;"&gt;&lt;span style="background-color: #fdfcfd; color: #3d1535; font-weight: bold; letter-spacing: -0.3px;"&gt;First, a Quick Primer: How the 340B Discount H&lt;/span&gt;&lt;span style="background-color: #fdfcfd; color: #3d1535; font-weight: bold; letter-spacing: -0.3px;"&gt;as Always Worked&lt;/span&gt;&lt;/h2&gt; 
&lt;/div&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://thepharmaforce.com/blog/the-capture/the-340b-rebate-model-what-just-happened-and-what-comes-next" title="" class="hs-featured-image-link"&gt; &lt;img src="https://thepharmaforce.com/hubfs/Capital%20Hill%20-%20The%20Capture.jpg" alt="The 340B Rebate Model: What Just Happened and What Comes Next" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;div style="color: #1a1a1a;"&gt; 
 &lt;h2 style="background-color: white; color: #5a5a6e;"&gt;&lt;span style="background-color: #fdfcfd; color: #3d1535; font-weight: bold; letter-spacing: -0.3px;"&gt;First, a Quick Primer: How the 340B Discount H&lt;/span&gt;&lt;span style="background-color: #fdfcfd; color: #3d1535; font-weight: bold; letter-spacing: -0.3px;"&gt;as Always Worked&lt;/span&gt;&lt;/h2&gt; 
&lt;/div&gt;  
&lt;img src="https://track.hubspot.com/__ptq.gif?a=46431067&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fthepharmaforce.com%2Fblog%2Fthe-capture%2Fthe-340b-rebate-model-what-just-happened-and-what-comes-next&amp;amp;bu=https%253A%252F%252Fthepharmaforce.com%252Fblog%252Fthe-capture&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>340B Policy Update</category>
      <category>Rebate Model</category>
      <pubDate>Fri, 27 Mar 2026 20:35:27 GMT</pubDate>
      <author>marketing@thepharmaforce.com (PharmaForce)</author>
      <guid>https://thepharmaforce.com/blog/the-capture/the-340b-rebate-model-what-just-happened-and-what-comes-next</guid>
      <dc:date>2026-03-27T20:35:27Z</dc:date>
    </item>
  </channel>
</rss>
